According to Lancet medical journal, Covaxin shots are 50 per cent effective against symptomatic COVID-19 patients. The study was conducted between April 15 and May 15 at AIIMS in New Delhi.

Covaxin 50 per cent effective against virus, says Lancet study

The Indian government on Wednesday said 0.03 per cent of people tested positive for coronavirus after taking the second dose of Covishield, while 0.04 per cent contracted the virus after receiving the second jab of Covaxin.

0.03% contracted Covid-19 after receiving second jab of Covishield; 0.04% post Covaxin

Bharat BioTech on Wednesday claimed that its coronavirus vaccine Covaxin has an efficacy of 78 per cent against mild, moderate and severe cases of Covid-19, according to the Phase 3 interim analysis results.

Covaxin has an efficacy of 78% against severe Covid-19 cases: Bharat BioTech